SE392721B - Forfarande for framstellning av peptider med psykofarmakologiska egenskaper - Google Patents

Forfarande for framstellning av peptider med psykofarmakologiska egenskaper

Info

Publication number
SE392721B
SE392721B SE7309861A SE7309861A SE392721B SE 392721 B SE392721 B SE 392721B SE 7309861 A SE7309861 A SE 7309861A SE 7309861 A SE7309861 A SE 7309861A SE 392721 B SE392721 B SE 392721B
Authority
SE
Sweden
Prior art keywords
procedure
preparing peptides
psychopharmacological properties
psychopharmacological
properties
Prior art date
Application number
SE7309861A
Other languages
English (en)
Swedish (sv)
Inventor
H M Greven
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of SE392721B publication Critical patent/SE392721B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • C07K14/6955Corticotropin [ACTH] with at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1027Tetrapeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7309861A 1972-07-15 1973-07-13 Forfarande for framstellning av peptider med psykofarmakologiska egenskaper SE392721B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (1)

Publication Number Publication Date
SE392721B true SE392721B (sv) 1977-04-18

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7309861A SE392721B (sv) 1972-07-15 1973-07-13 Forfarande for framstellning av peptider med psykofarmakologiska egenskaper

Country Status (13)

Country Link
US (1) US3853838A (fr)
JP (1) JPS5936611B2 (fr)
AU (1) AU471401B2 (fr)
BE (1) BE802335A (fr)
CA (1) CA1019723A (fr)
CH (1) CH605674A5 (fr)
DE (1) DE2335826C2 (fr)
FR (1) FR2192838B1 (fr)
GB (1) GB1439225A (fr)
HU (1) HU169437B (fr)
NL (1) NL175618C (fr)
SE (1) SE392721B (fr)
ZA (1) ZA734648B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
JPS62501147A (ja) * 1984-12-14 1987-05-07 オーストラリアン コマーシャル リサーチ アンド ディベロップメント リミティド ヒト白血球エラスタ−ゼのアミノ酸阻害剤及びペプチド阻害剤
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
ES2710617T3 (es) 2010-04-21 2019-04-26 Signature Therapeutics Inc Composiciones que comprenden profármacos de anfetamina escindibles enzimáticamente e inhibidores de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (fr) * 1961-05-04 1900-01-01
NL6509727A (fr) * 1965-07-28 1967-01-30
GB1230472A (fr) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
GB1439225A (en) 1976-06-16
AU5798373A (en) 1975-01-16
AU471401B2 (en) 1976-04-29
CH605674A5 (fr) 1978-10-13
CA1019723A (en) 1977-10-25
DE2335826A1 (de) 1974-01-31
NL175618C (nl) 1984-12-03
JPS5936611B2 (ja) 1984-09-05
FR2192838B1 (fr) 1977-01-28
ZA734648B (en) 1974-06-26
HU169437B (fr) 1976-11-28
JPS4951278A (fr) 1974-05-18
NL7209839A (fr) 1974-01-17
BE802335A (fr) 1974-01-14
FR2192838A1 (fr) 1974-02-15
US3853838A (en) 1974-12-10
NL175618B (nl) 1984-07-02
DE2335826C2 (de) 1984-01-05

Similar Documents

Publication Publication Date Title
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE415261B (sv) Forfarande for framstellning av berarbundna polypeptider
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
NO141568C (no) Fremgangsmaate for fremstilling av cellulosemasse med hoey lyshet
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE392613B (sv) Forfarande for framstellning av peptider med psykofarmakologiska egenskaper
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
NO140828C (no) Fremgangsmaate for fremstilling av pullulan
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE382550B (sv) Forfarande for framstellning av livsmedel innehallande pullulan
IT1002557B (it) Procedimento per preparare dimetil naftaline
SE392721B (sv) Forfarande for framstellning av peptider med psykofarmakologiska egenskaper
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE415146B (sv) Forfarande for framstellning av forbettrad epoxideringskatalysator
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE410603B (sv) Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
IT999554B (it) Procedimento per preparare diacetossibutano
SE386664B (sv) Forfarande for framstellning av cystinhaltiga peptider
RO69492A2 (fr) Procede pour la preparation de perchlore-methyle-mercaptane
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider